Thema
Adalimumab
171
Infliximab
127
Crohn’s disease
64
FYS6T7F842
61
Journal Article
59
Inflammatory bowel disease
50
B72HH48FLU
45
Ulcerative colitis
38
Tumor Necrosis Factor-alpha
30
Anti-Inflammatory Agents
25
Gastrointestinal Agents
21
Anti-TNF
20
Research Support, Non-U.S. Gov't
18
Antibodies, Monoclonal, Humanized
17
Antibodies, Monoclonal
15
Biological Products
15
Inflammatory Bowel Disease
12
Therapeutic drug monitoring
12
Observational Study
11
Tumor Necrosis Factor Inhibitors
11
Azathioprine
9
Biological therapy
9
Certolizumab
9
Crohn disease
9
Multicenter Study
9
Research Support, N.I.H., Extramural
9
Tumor necrosis factor alpha
9
Anti-TNF agents
8
Case Reports
8
Mucosal healing
8
Anti-TNF therapy
7
9RV78Q2002
5
Antibodies
5
Antirheumatic Agents
5
Biochemistry, general
5
Biologics
5
Certolizumab Pegol
5
Colectomy
5
Combination therapy
5
Comparative Study
5
Dose escalation
5
Editorial
5
Gastroenterology
5
Hepatology
5
IBD
5
Korea
5
Loss of response
5
Medicine & Public Health
5
Oncology
5
Pediatric IBD
5
mehr ...